Bharat Biotech International and the University of Sydney Infectious Diseases Institute have inked a Memorandum of Understanding (MoU) to advance vaccine research initiatives, strengthen academic-industry partnerships and augment global efforts to combat infectious diseases. Bharat Biotech is a world-leading vaccine and biotherapeutics manufacturer. During the Covid pandemic, it made the vaccine Covaxin, which was administered […]
Read Time : 1 Minutes
India’s first intranasal vaccine by Bharat Biotech gets DCGI approval
The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine. This will be India’s first nasal vaccine for COVID-19. Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a ‘Big boost’ to India’s fight against Covid-19. […]
Read Time : 3 Minutes
Covaxin safe for children aged 2-18 years, says Bharat Biotech
Bharat Biotech International Limited (BBIL) on Thursday announced that Covaxin, its whole-virion inactivated COVID-19 vaccine has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study, said a press release. The study has been accepted and published in Lancet Infectious Diseases, a peer-reviewed high-impact factor […]
Read Time : 3 Minutes
Germany to recognize Bharat Biotech’s COVAXIN for travel from June 1
German Ambassador to India, Walter J Lindner, on Thursday hailed the German government for recognizing the WHO-listed Bharat Biotech’s COVID vaccine, COVAXIN, for travel to the country starting June 1. World Health Organization (WHO) in November last year issued an emergency use listing (EUL) for COVAXIN, adding to a growing […]
Read Time : 1 Minutes
Bharat Biotech seeks DCGI’s permission to conduct Covaxin booster trials in 2-18 age group
Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said. The company has applied for permission a week ago. It has already conducted trials in the age […]
Read Time : 1 Minutes
Bharat Biotech asked to provide more data on Covid-19 vaccine Covaxin for below 12-year-olds
The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said. This development comes after the Subject Expert Committee discussed recommendations for the restricted emergency […]
Read Time : 4 Minutes
Covaxin true success story of public-private partnership, says Bharat Biotech Chairman
The development of the country’s indigenous COVID-19 vaccine Covaxin is a true success story for public-private partnerships in India, which is based on mutual respect, trust and transparency, said Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech. Speaking at the launch of “Going Viral, Making of Covaxin: The Inside Story” book, Dr Ella […]
Read Time : 2 Minutes
WHO to decide on Bharat Biotech’s Covaxin emergency usage in October
The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech’s submission on emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October 2021. The status of assessment for Covaxin is “ongoing” as of now, the WHO informed in a document citing […]
Read Time : 2 Minutes
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine efficacy of 78.8 pc against Covid-19
Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 percent effective against COVID-19. It also added that Covaxin gives 65.2 percent protection against the SARS-CoV-2, B.1.617.2 Delta variant. “Efficacy analysis demonstrates Covaxin to be 77.8 percent effective against symptomatic COVID-19, through […]
Read Time : 5 Minutes
Bharat Biotech’s nasal vaccine for Covid-19 likely to be a game-changer
In the summer of the year 2020, the chairman and managing director of India’s premier vaccine developing company, Bharat Biotech International Limited told the reporter that while efforts were on to develop an intramuscular vaccine against Covid-19, what he really would want to do is develop a vaccine that will […]
Read Time : 1 Minutes
Brazil signs Covid-19 vaccine deal with Bharat Biotech
On the same day, Brazil reached the grim milestone of 250,000 deaths by COVID-19, the country’s health ministry signed a deal with Indian pharmaceutical company Bharat Biotech for the purchase of 20 million doses of the Covaxin Vaccines, which is yet to be approved by local regulators. The administration of President Jair […]
Read Time : 3 Minutes
India’s Bharat Biotech seeks Bangladesh trial for Covid vaccine approved at home
India’s Bharat Biotech has applied to conduct trials in Bangladesh for its coronavirus vaccine recently approved for emergency use at home, a senior official at Bangladesh’s main medical research body told Reuters. If allowed to go ahead, this would be the first trial of any coronavirus vaccine in Bangladesh and […]